Call Now

Peritoneal Fibrosis (PF)

PF; Peritoneal Fibrosis

Peritoneal fibrosis is one of the most serious complications of peritoneal dialysis, and is characterized by the activation of peritoneal resident cells, induction of pro-fibrotic peptides, accumulation and deposition of excess matrix proteins within the submesothelium, and vasculopathy of the peritoneal microvasculature. Peritoneal fibrosis is a serious complication in patients with end stage renal disease (ESRD), especially those undergoing long-term peritoneal dialysis therapy. Since the peritoneum is a major site of mast cell accumulation, and since mast cells are known to facilitate the progression of organ fibrosis, they would also contribute to the pathogenesis of peritoneal fibrosis.

Organism species: Pan-species (General)

Proteins N/A Recombinant Peritoneal Fibrosis (PF) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Peritoneal Fibrosis (PF) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Peritoneal Fibrosis (PF) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Peritoneal Fibrosis (PF) CLIA Kit Customized Service Offer
N/A ELISA Kit for Peritoneal Fibrosis (PF) ELISA Kit Customized Service Offer